Germline mutations of BRCA1/2 were found in around 7% of breast [5] and pancreatic cancers [6], and in 15% of ovarian cancers [7], but only in 1.5% of prostate cancers [8]. This evidence concerns the gene BRCA1 and prostate carcinoma.